CUREDirexion Daily Healthcare Bull 3x Shares
CURE Fund Description
CURE provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies.
CURE Factset Analytics Insight
As a levered product, CURE is not a buy-and-hold ETF, it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare names—like J&J, Pfizer, and Merck—in the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. As a short-term product, CURE's expense ratio is less important than all in trading costs. Trading can be volatile. Check the latest Tradability data on this page.
CURE MSCI ESG Analytics Insight
Direxion Daily Healthcare Bull 3x Shares has an MSCI ESG Fund Rating of BBB based on a score of 5.22 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Direxion Daily Healthcare Bull 3x Shares ranks in the 29th percentile within its peer group and in the 22nd percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.
CURE Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of CURE. CURE is rated a N/A out of 5.